ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it will be participating at the European Society of Human Reproduction and Embryology's (ESHRE) 40th Annual Meeting in Amsterdam on July 7-10. The Company will be exhibiting at booth #11,111. The conference follows Femasys receiving C ...